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Abstract
Introduction—Postpartum screening for glucose intolerance among women with recent histories 
of gestational diabetes mellitus (GDM) is important for identifying women with continued glucose 
intolerance after birth, yet screening rates are suboptimal. In a thorough review of the literature, 
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we found no studies of screening practices among certified nurse-midwives (CNMs). The 
objectives of our study were to estimate the prevalence of postpartum screening for abnormal 
glucose tolerance and related care by CNMs for women with recent histories of GDM and to 
identify strategies for improvement.
Methods—From October through December 2010, the Ohio Department of Health sent a survey 
by mail and Internet to all licensed CNMs practicing in Ohio. We calculated prevalence estimates 
for knowledge, attitudes, clinical practices, and behaviors related to postpartum diabetes screening. 
Chi-square statistics were used to assess differences in self-reported clinical behaviors by 
frequency of postpartum screening.
Results—Of the 146 CNMs who provided postpartum care and responded to the survey (62.2% 
response rate), 50.4% reported screening women with GDM-affected pregnancies for abnormal 
glucose tolerance at the postpartum visit. Of CNMs who screened postpartum, only 48.4% used 
fasting blood sugar or the 2-hour oral glucose tolerance test. Although 86.2% of all responding 
CNMs reported that they inform women with recent histories of GDM of their increased risk for 
type 2 diabetes mellitus, only 63.1% counseled these women to exercise regularly and 23.3% 
reported referring overweight/obese women to a diet support group or other nutrition counseling. 
CNMs reported that identification of community resources for lifestyle interventions and 
additional training in postpartum screening guidelines may help to improve postpartum care.
Discussion—CNMs in Ohio reported suboptimal levels of postpartum diabetes testing and use 
of a recommended postpartum test. Providing CNMs with additional training and identifying 
community resources to support needed lifestyle behavior change may improve care for women 
with recent GDM-affected pregnancies.
Keywords
gestational diabetes mellitus; glucose tolerance test; postpartum care; nurse-midwives; women’s 
health
INTRODUCTION
Gestational diabetes mellitus (GDM) affects 2% to 10% of pregnancies in the United 
States.1 Approximately 30% of US women with GDM continue to have glucose 
abnormalities after birth.2–4 A systematic review of studies that followed women with GDM 
for 1 or more years after birth documented that up to 50% of women developed type 2 
diabetes within 5 years of a GDM pregnancy and up to 70% of women developed type 2 
diabetes within 10 years.5 Currently, an estimated 8.3% of the US adult population has 
diabetes6; by 2050, the prevalence of diabetes is expected to rise to 21% to 33%.7 The onset 
of type 2 diabetes can be prevented or delayed through good nutrition, exercise, maintenance 
of a healthy weight, and breastfeeding.8–10 The American Diabetes Association (ADA), the 
American College of Obstetrics and Gynecologists, and the World Health Organization 
recommend that women with GDM pregnancies be tested for abnormal glucose tolerance 6 
to 12 weeks postpartum.11–13 In addition, the ADA recommends that all women with a 
history of GDM be educated about lifestyle modification, whereas the American College of 
Obstetricians and Gynecologists recommends women with additional risk factors such as 
obesity receive diet, exercise, and weight management counseling.12
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Although postpartum testing is needed to diagnose type 2 diabetes, a recent systematic 
review of studies based on medical chart records or practitioner self-report found that only 
34% to 73% of women with GDM received postpartum screening,14 and other studies found 
20% to 74% of obstetrician-gynecologists reported providing postpartum screening.15,16 
Certified nurse-midwives (CNMs) provide care to women before, during, and after 
pregnancy, and care for a substantial portion of uninsured and Medicaid-insured 
patients.17,18 In 2009, CNMs attended 7.6% of total births in the United States,19 yet their 
postpartum care practices for women with recent histories of GDM are unknown.
To assess the need for improving early detection and preventing type 2 diabetes among 
women in Ohio with a history of GDM, the Ohio Department of Health, in conjunction with 
the Centers for Disease Control and Prevention (CDC) surveyed CNMs to estimate the 
prevalence of postpartum diabetes screening and lifestyle modification counseling for 
women with a recent history of GDM. In addition, we gathered information on resource and 
training needs to improve care.
METHODS
A team from the Ohio Department of Health and the CDC developed a 37-item 
questionnaire that assessed providers’ knowledge, attitudes, and postpartum practices 
regarding diabetes prevention for women with a history of GDM. The questionnaire required 
approximately 15 to 20 minutes per respondent to complete, was reviewed for face validity, 
and was piloted with 5 CNMs. The pilot test identified questions that were confusing, 
problems with skip patterns, additional response choices, and grammatical errors. The 
questionnaire was revised to address each of these issues.
The population-based study sample included all CNMs with current certificates of authority 
listed in public access state licensure files (n = 280). From October through December 2010, 
we mailed surveys to CNMs using a dual-mode (mail and Internet) approach to optimize 
response rates.20 Postcards were first mailed to the CNMs to notify them of the forthcoming 
survey. The paper questionnaire was then mailed with options to complete online or by 
return mail. Reminder postcards were sent a week later, followed in one week by mailed 
duplicate surveys to nonresponders. Reminder e-mailswere sent to nonresponders if the 
duplicate survey was not returned within 2 weeks.
A database was created for respondents’ responses. Surveys completed online were directly 
entered into this database; surveys returned by mail were entered into the database via 
Teleform software (Autonomy, 2009). All data were analyzed using Stata 10.0 (StataCorp, 
2007). Questions regarding knowledge and attitudes were assessed on a 5-item Likert scale, 
with responses “strongly agree,” “somewhat agree,” “unsure,” “somewhat disagree,” and 
“strongly disagree.” Responses of “strongly disagree” and “somewhat disagree” were 
grouped together as “disagree.” Questions related to postpartum screening and care practices 
were assessed on a 5-item Likert scale. The responses of “always” and “most of the time” 
were grouped as positive responses. The responses “sometimes,” “rarely,” and “never” were 
grouped as negative responses. We used chi-square tests to assess statistical differences by 
clinical behaviors for categorical variables. The findings were considered significant at P 
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less than or equal to .05. The survey was determined to be public health practice and was 
exempted from institutional review board approval.
RESULTS
Characteristics of the Certified Nurse-Midwives
Of 280 practicing CNMs in Ohio, 31 CNMs were excluded from participation in this study 
because they had participated in the pilot testing (n = 5) or because they had declined 
participation, retired, moved out of state, or indicated they practiced in a different specialty 
(n = 26). Of the remaining eligible 249 CNMs, 155 responded to the survey, yielding a 
response rate of 62.2% (n = 155/249). Among respondents, 146 CNMs (94.2%) indicated 
that they provided postpartum care. All CNMs were female, and mean years in practice was 
13.3 years (Table 1). Less than half the CNMs reported working in a private practice 
(48.0%). More than half of CNMs (55.2%) reported that the majority of their patients were 
Medicaid-insured. Almost three-quarters of CNMs (71.9%) saw 6 to 20 new pregnant 
patients per month. Approximately 87% of CNMs reported that their patient population 
mainly resided in urban and suburban areas.
Knowledge and Attitudes of Certified Nurse-Midwives
The majority of CNMs (86.5%) stated that type 2 diabetes screening for women with 
histories of GDM was a low(54.6%) or moderate (31.9%) priority in their practice, and 
approximately one-third (35.0%) correctly identified that more than 40% of women with 
GDM during pregnancy will progress to type 2 diabetes within 10 years (Table 2). Three-
fourths of CNMs (74.1%) strongly agreed that GDM has long-term implications for a 
woman’s health, and 65.0% strongly agreed that periodic screening for type 2 diabetes is 
needed among women with a history of GDM.
Clinical Practices
Although 73.2% of CNMs reported that they discuss a woman’s plan for postpartum testing 
if she has GDM, only 50.4% stated that they screen for abnormal glucose tolerance after a 
GDM pregnancy at the postpartum visit (Table 3). There were no differences in postpartum 
screening rates by number of years in practice, practice type (eg, private group, hospital), 
percentage of practice that was Medicaid-insured, primary population race/ethnicity, or 
location (rural/suburban/urban); P greater than .05 for each (data not shown). The majority 
of CNMs (86.2%) reported telling their patients with recent histories of GDM that they have 
an increased risk for type 2 diabetes, but fewer CNMs (63.9%) reported telling women with 
recent histories of GDM that they should be tested for diabetes when considering or 
becoming pregnant in the future. Counseling women with recent histories of GDM to 
exercise regularly was reported more frequently (63.1%) than referring overweight or obese 
women with recent histories of GDM to diet support groups or other nutrition counseling 
(23.3%). The majority of CNMs encouraged women with recent GDM pregnancies to 
breastfeed (96.1%).
The most common strategy reported for ensuring postpartum screening for abnormal glucose 
tolerance after aGDM pregnancy was discussing the need for postpartum testing with 
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patients (61.0%; Figure 1). CNMs less frequently offered educational material to patients, 
called or mailed reminders to patients, or used alerts in the electronic medical record to 
remind the provider of their patients’ GDM histories.
The CNMs who always/most of the time screened for abnormal glucose tolerance at the 
postpartum visit were more likely to discuss the need for postpartum testing for type 2 
diabetes compared with CNMs who screened less often (89.2% vs 46.9%; P < .001). 
Similarly, the CNMs who always/most of the time screened, reviewed a woman’s plan for 
postpartum testing more often than did the CNMs who screened less often (90.3% vs 57.6%; 
P < .001). They also were more likely to counsel women to exercise regularly (75.0% vs 
53.1%; P =.03) and to have clinical systems or materials in place that supported postpartum 
testing such as having clinical protocols that address postpartum type 2 diabetes screening 
(54.0% vs 10.0%; P < .001), appointment reminders for patients (12.3% vs 0%; P < .004), 
and patient educational materials (18.5% vs 1.6%; P = .001).
CNMs who always/most of the time and CNMs who sometimes/rarely/never screen for 
postpartum glucose intolerance did not differ in the following clinical practices: telling 
postpartum women that they were at increased risk for type 2 diabetes, telling women that 
they should be tested for diabetes when considering having another child or becoming 
pregnant in the future, encouraging women with a recent GDM pregnancy to breastfeed, and 
referring overweight or obese postpartum women with a recent history of GDM to a diet 
support group or other nutrition counseling (all P > .05). In addition, there were no 
differences by frequency of postpartum screening in the use of electronic alerts to remind a 
provider of the need for a postpartum glucose test (P > .05).
Among CNMs who always/most of the time screened for abnormal glucose tolerance at the 
postpartum visit, the 2-hour oral glucose tolerance test (OGTT) was the most common type 
of postpartum glucose tolerance test used (45.2%; Figure 2). Fewer than half of CNMs 
(48.4%) reported using a recommended postpartumtest for glucose intolerance: fasting blood 
sugar (FBS) or the 2-hour OGTT test.
Resources Needed for Improved Care
Approximately half of all responding CNMs (49.3%) reported a need for improved GDM 
patient education, and 71.9% reported a need for increased patient responsibility for self-
preventive care. Almost half the CNMs reported needing additional training on postpartum 
screening recommendations (45.2%). CNMs who sometimes, rarely, or never screened for 
type 2 diabetes were more likely to state they needed training related to postpartum 
screening recommendations (P < .001; data not shown). Fewer than a third of responding 
CNMs reported needing additional training in risk factor identification/modification 
(28.8%). CNMs also reported that a listing of community-based programs that target risk 
factor modification (65.1%), automatic reminders in patient charts or in electronic medical 
records to alert providers to order postpartum tests for GDM patients (46.6%), and increased 
communication between the obstetrician-gynecologist and the primary care physician 
(31.5%) would be beneficial.
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Only half of responding Ohio CNMs reported screening their postpartum patients for 
glucose tolerance after a GDM pregnancy always or most of the time. Most CNMs 
understood that GDM poses risks for a woman’s long-term health and informed their 
patients of this risk; however, approximately two-thirds underestimated or were unaware that 
greater than 40% of women with GDM pregnancies ultimately develop type 2 diabetes. 
CNMs most frequently suggested patient- and system-level strategies for improved care, but 
also indicated a desire for additional training in postpartum screening recommendations. 
Although we found no other studies that reported postpartum diabetes screening rates among 
CNMs only, studies that combined obstetrician-gynecologists and CNMs21 or that focused 
on obstetrician-gynecologists16 described wide variation in reported screening rates. For 
example, a statewide survey in North Carolina found that collectively only 27% of 
responding obstetrician-gynecologists, nurse-midwives, and primary care practitioners 
screened for type 2 diabetes during postpartum visits for patients with recent histories of 
GDM.21 In contrast, a national survey of American College of Obstetricians and 
Gynecologists fellows and junior fellows found that approximately 74% of obstetricians 
routinely perform postpartum evaluations of glucose tolerance in patients diagnosed with 
GDM.16
Studies have documented that postpartum screening rates can improve with patient 
education and counseling,22 mailed reminders to the patient and her health practitioner,23 
and use of a case-manager nurse to follow up with patients during and after pregnancy.24 
Use of reminders in electronic medical records or automated telephone reminder systems 
have been shown to improve patient compliance with screening for other types of tests such 
as mammography and colon cancer and would likely improve postpartum diabetes screening 
as well.25,26 Given the low percentages of CNMs reporting the use of educational materials, 
reminder calls or mailings, and electronic alerts in this survey, increased use of these 
strategies may improve postpartum type 2 diabetes screening in Ohio.
Only 48% of CNMs who screen women at the postpartum visit reported using either of the 2 
recommended tests (OGTT or the FBS) for postpartum screening,12,27 which is similar to 
estimates from other studies that found 54% of obstetrician-gynecologists, nurse-midwives, 
and primary care practitioners in North Carolina21 and 50.8% of American College of 
Obstetricians and Gynecologists fellows who provide postpartum screening used the 
OGTT.16 Although both the American College of Obstetricians and Gynecologists and the 
ADA endorse the OGTT and FBS as acceptable postpartum glucose tolerance tests,12,27 the 
American College of Nurse-Midwives (ACNM) has not put forward specific postpartum 
glucose tolerance testing guidelines. Increased use of recommended postpartum tests can be 
achieved with ongoing provider education.
Although the primary focus of this study was on postpartum diabetes screening, there are 
some additional clinical implications to note. CNMs serve a patient population that is 
disproportionally vulnerable to poor health care access and at risk for poor pregnancy 
outcomes.17,18 Thus, the postpartum visit is an opportunity not only to screen for glucose 
tolerance and educate women with recent GDM pregnancies on their increased risk of type 2 
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diabetes, but also to provide counseling on the importance of physical activity and referrals 
to appropriate nutrition resources. Although the ADA recommends that all women with a 
history of GDM be educated about lifestyle modification,27 only 63% of responding CNMs 
in this study counseled women with recent histories of GDM to exercise regularly, and fewer 
than one-third of CNMs referred overweight/obese postpartum women with recent GDM 
histories to a diet support group or other nutrition counseling. This may reflect a lack of 
services available in the community or that the clinics do not have a referral list for these 
types of services. Guidelines from the American College of Obstetricians and Gynecologists 
recommend that women with recent GDM pregnancies who have additional risk factors for 
type 2 diabetes such as obesity receive diet, exercise, and weight management counseling.12 
One-third of CNMs in this study desired additional training in risk factor identification and 
modification, which could increase counseling and referral of women to lifestyle 
modification services.
Our study has some limitations. First, these data are based on self-report and could be 
subject to social desirability bias; thus, respondents may have overestimated their frequency 
of postpartum screening and lifestyle modification counseling. In addition, CNMs who 
completed the survey may be more interested in and aware of GDM than those who did not 
participate and were therefore more likely to follow recommended guidelines in their care of 
women with recent histories of GDM. Thus, results from this survey may not fully represent 
the practices of all CNMs in Ohio. Despite these limitations, this study’s use of a dual-mode 
survey design allowed us to capture more respondents than would be reached by exclusively 
phone- or mail-based methodologies. Although the response rate was moderate, at 62.2%, it 
was relatively high compared with surveys of physicians, which typically have response 
rates of 40% or less.16,21 This is the first study, to our knowledge, to provide prevalence 
estimates for knowledge, attitudes, clinical practices, and behaviors related to postpartum 
diabetes screening specific to CNMs. Because these CNMs practice across the state in a 
variety of clinical settings, we were able to capture clinical practices in many locations, 
instead of only one medical center or academic institution. Findings from this study may be 
generalizable to other states with similar patient and CNM populations.
CONCLUSION
In summary, CNMs in Ohio reported suboptimal levels of postpartum diabetes testing for 
their GDM patients, with fewer than 50% of responding participants reporting that they use 
a recommended test, educate patients on their future risk of type 2 diabetes, and provide 
referrals to lifestyle interventions. Effective strategies at multiple levels may be needed to 
improve care for women with GDM-affected pregnancies. At the patient level, improved 
education and self-preventive care may improve outcomes. The Ohio Department of Health 
is conducting focus group research to learn about women’s barriers and to test educational 
messages. At the provider level, training on screening recommendations and risk factor 
identification and modification should be well accepted by CNMs; the Ohio Department of 
Health is developing Web-based training for nursing continuing education credits. Such 
provider education should also be offered by ACNM on a national level. As CNMs indicated 
a need for community-based programs and for automatic reminders in electronic medical 
records to ensure completion of the postpartum test, the Department of Health may explore 
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collaborations in the community and with clinical providers to develop these improvements. 
At the system level, improving continuity of care and continued access to health insurance 
after birth are needed.
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✦ This study assessed the screening and counseling that Ohio certified nurse-
midwives (CNMs) provide for postpartum women who have had gestational 
diabetes.
✦ Only half of responding CNMs reported screening their postpartum patients for 
glucose tolerance after a gestational diabetes mellitus (GDM) pregnancy.
✦ Among CNMs who screen postpartum, only half reported using one of the 
recommended postpartum glucose tolerance tests.
✦ About two-thirds of CNMs counseled women with recent histories of GDM to 
exercise regularly; however, only one-quarter of CNMs referred overweight or 
obese women with recent GDM histories to diet support groups or other 
nutrition counseling.
✦ Midwives need to consistently screen postpartum women who have had a GDM 
pregnancy for glucose tolerance using either a fasting blood sugar or a 2-hour 
oral glucose test and to encourage these women to exercise regularly and lose 
weight if they are overweight or obese.
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Figure 1. Activities of Certified Nurse-Midwives’ Practices to Ensure Women with Gestational 
Diabetes Mellitus Receive a Postpartum Test (N= 146)a
aRespondents could select more than one activity, thus percentages do not add up to 100%. 
Of the 146 respondents, 36.9% (n = 54) did not report use of any of the above activities to 
ensure women receive a postpartum test.
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Figure 2. Glucose Tolerance Tests Used by Certified Nurse-Midwives who Provide Postpartum 
Screening Always/Most of the time (n = 65)
aRecommended postpartum glucose tolerance tests by the American College of 
Obstetricians and Gynecologists and the American Diabetes Association.10,11
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Table 1
Characteristics of Certified Nurse-Midwives (N = 146)a
Characteristics n (%)
Years in practice, mean (SE) 13.3(8.2)
Sex
  Female 146(100)
   Male 0(0)
Primary practice type
  Private group 70(48.0)
  Government-funded clinic 30(20.6)
  Hospital 37(25.3)
  University 5(3.4)
  Other (includes HMO) 4(2.7)
Percentage of patients insured by Medicaid
  0%–25% 19(14.2)
  26%–50% 41(30.6)
  51%–75% 33(24.6)
  >75% 41(30.6)
New pregnancies typically seen each month
  1–5 12(9.4)
  6–10 44(34.4)
  11–20 48(37.5)
  ≥21 24(18.8)
Primary patient residence
  Urban 74(51.0)
  Suburban 52(35.9)
  Rural 19(13.1)
Abbreviations: HMO, health maintenance organization; SE, standard error.
a
Sample included 146 certified nurse-midwives who provided postpartum care; however, because of missing data, some columns do not sum up to 
146 respondents.
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Table 2
Knowledge and Attitudes Among Certified Nurse-Midwives Regarding Gestational Diabetes Mellitus (N = 
146)a
Question n (%)
Screening for type 2 diabetes among
    nonpregnant women with a
    history of GDM is a _ priority in
    my practice
  High 19 (13.5)
  Moderate 45 (31.9)
  Low 77 (54.6)
Percentage of women with GDM
    pregnancies who will progress
    to type 2 diabetes within 10
    years?
  >40% 50 (35.0)
  ≤40% 77 (53.9)
  Unsure 16 (11.2)
GDM has long-term implications for
    a woman’s health
  Strongly agree 106 (74.1)
  Somewhat agree 34 (23.8)
  Disagree 2 (1.4)
  Unsure 1 (0.7)
There is a need for periodic
    screening for type 2 diabetes
    among women with a history of
    GDM
  Strongly agree 93 (65.0)
  Somewhat agree 41 (28.7)
  Disagree 3 (2.1)
  Unsure 6 (4.2)
Abbreviation: GDM, gestational diabetes mellitus.
a
Sample included 146 certified nurse-midwives who provided postpartum care; however, because of missing data, some columns do not sum up to 
146 respondents.
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Table 3
Clinical Practices of Certified Nurse-Midwives (N = 146)a
n (%)
If a woman has GDM, I discuss her plans for follow-up postpartum care for testing of type 2 diabetes.
  Always/most times 93 (73.2)
  Some of the time 20 (15.8)
  Never/rarely 14 (11.0)
At the postpartum visit, women are screened for abnormal glucose tolerance after a GDM pregnancy.
  Always/most times 65 (50.4)
  Some of the time 30 (23.3)
  Never/rarely 34 (26.4)
Postpartum women with a recent history of GDM are told that they are at an increased risk for type 2 diabetes.
  Always/most times 112 (86.2)
  Some of the time 13 (10.0)
  Never/rarely 5 (3.9)
In addition to routine screening, postpartum women with a recent history of GDM are told that they should
    be tested for diabetes when becoming pregnant in the future.
  Always/most times 83 (63.9)
  Some of the time 27 (20.8)
  Never/rarely 20 (15.4)
Postpartum women with a recent history of GDM are counseled to exercise regularly.
  Always/most times 82 (63.1)
  Some of the time 35 (26.9)
  Never/rarely 13 (10.0)
Overweight or obese postpartum women with a recent history of GDM are referred to a diet support group or
    other nutrition counseling.
  Always/most times 30 (23.3)
  Some of the time 40 (31.0)
  Never/rarely 59 (45.7)
I encourage women with a recent GDM pregnancy to breastfeed.
  Always/most times 123 (96.1)
  Some of the time 1 (0.8)
  Never/rarely 4 (3.1)
Abbreviation: GDM, gestational diabetes mellitus.
a
Sample included 146 certified nurse-midwives who provided postpartum care; however, because of missing data, some columns do not sum up to 
146 respondents.
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